Sailer M - Search Results

1

T1 lesion load and cerebral atrophy as a marker for clinical progression in patients with multiple sclerosis. A prospective 18 months follow-up study.

Sailer M, Losseff NA, Wang L, Gawne-Cain ML, Thompson AJ, Miller DH. Sailer M, et al. Eur J Neurol. 2001 Jan;8(1):37-42. doi: 10.1046/j.1468-1331.2001.00147.x. Eur J Neurol. 2001. PMID: 11509079

2

Quantitative MRI in patients with clinically isolated syndromes suggestive of demyelination.

Sailer M, O'Riordan JI, Thompson AJ, Kingsley DP, MacManus DG, McDonald WI, Miller DH. Sailer M, et al. Neurology. 1999 Feb;52(3):599-606. doi: 10.1212/wnl.52.3.599. Neurology. 1999. PMID: 10025795

3

Serum inflammatory markers and clinical/MRI markers of disease progression in multiple sclerosis.

Giovannoni G, Miller DH, Losseff NA, Sailer M, Lewellyn-Smith N, Thompson AJ, Thompson EJ. Giovannoni G, et al. Among authors: sailer m. J Neurol. 2001 Jun;248(6):487-95. doi: 10.1007/s004150170158. J Neurol. 2001. PMID: 11499639

4

A longitudinal study of abnormalities on MRI and disability from multiple sclerosis.

Brex PA, Ciccarelli O, O'Riordan JI, Sailer M, Thompson AJ, Miller DH. Brex PA, et al. Among authors: sailer m. N Engl J Med. 2002 Jan 17;346(3):158-64. doi: 10.1056/NEJMoa011341. N Engl J Med. 2002. PMID: 11796849 Free article.

5

Influence of cerebral lesion volume and lesion distribution on event-related brain potentials in multiple sclerosis.

Sailer M, Heinze HJ, Tendolkar I, Decker U, Kreye O, v Rolbicki U, Münte TF. Sailer M, et al. J Neurol. 2001 Dec;248(12):1049-55. doi: 10.1007/s004150170024. J Neurol. 2001. PMID: 12013581 Clinical Trial.

6

Escalating immunotherapy of multiple sclerosis--new aspects and practical application.

Rieckmann P, Toyka KV, Bassetti C, Beer K, Beer S, Buettner U, Chofflon M, Götschi-Fuchs M, Hess K, Kappos L, Kesselring J, Goebels N, Ludin HP, Mattle H, Schluep M, Vaney C, Baumhackl U, Berger T, Deisenhammer F, Fazekas F, Freimüller M, Kollegger H, Kristoferitsch W, Lassmann H, Markut H, Strasser-Fuchs S, Vass K, Altenkirch H, Bamborschke S, Baum K, Benecke R, Brück W, Dommasch D, Elias WG, Gass A, Gehlen W, Haas J, Haferkamp G, Hanefeld F, Hartung HP, Heesen C, Heidenreich F, Heitmann R, Hemmer B, Hense T, Hohlfeld R, Janzen RW, Japp G, Jung S, Jügelt E, Koehler J, Kölmel W, König N, Lowitzsch K, Manegold U, Melms A, Mertin J, Oschmann P, Petereit HF, Pette M, Pöhlau D, Pohl D, Poser S, Sailer M, Schmidt S, Schock G, Schulz M, Schwarz S, Seidel D, Sommer N, Stangel M, Stark E, Steinbrecher A, Tumani H, Voltz R, Weber F, Weinrich W, Weissert R, Wiendl H, Wiethölter H, Wildemann U, Zettl UK, Zipp F, Zschenderlein R, Izquierdo G, Kirjazovas A, Packauskas L, Miller D, Koncan Vracko B, Millers A, Orologas A, Panellus M, Sindic CJ, Bratic M, Svraka A, Vella NR, Stelmasiak Z, Selmaj K, Bartosik-Psujik H, Mitosek-Szewczyk K, Belniak E, Mochecka A, Bayas A, Chan A, Flachenecker … See abstract for full author list ➔ Rieckmann P, et al. Among authors: sailer m. J Neurol. 2004 Nov;251(11):1329-39. doi: 10.1007/s00415-004-0537-6. J Neurol. 2004. PMID: 15592728 Review.

7

Subgroups of the BENEFIT study: risk of developing MS and treatment effect of interferon beta-1b.

Polman C, Kappos L, Freedman MS, Edan G, Hartung HP, Miller DH, Montalbán X, Barkhof F, Selmaj K, Uitdehaag BM, Dahms S, Bauer L, Pohl C, Sandbrink R; BENEFIT investigators. Polman C, et al. J Neurol. 2008 Apr;255(4):480-7. doi: 10.1007/s00415-007-0733-2. Epub 2007 Nov 15. J Neurol. 2008. PMID: 18004635 Clinical Trial.

8

Focal thinning of the cerebral cortex in multiple sclerosis.

Sailer M, Fischl B, Salat D, Tempelmann C, Schönfeld MA, Busa E, Bodammer N, Heinze HJ, Dale A. Sailer M, et al. Brain. 2003 Aug;126(Pt 8):1734-44. doi: 10.1093/brain/awg175. Epub 2003 Jun 4. Brain. 2003. PMID: 12805100

9

The 11-year long-term follow-up study from the randomized BENEFIT CIS trial.

Kappos L, Edan G, Freedman MS, Montalbán X, Hartung HP, Hemmer B, Fox EJ, Barkhof F, Schippling S, Schulze A, Pleimes D, Pohl C, Sandbrink R, Suarez G, Wicklein EM; BENEFIT Study Group. Kappos L, et al. Neurology. 2016 Sep 6;87(10):978-87. doi: 10.1212/WNL.0000000000003078. Epub 2016 Aug 10. Neurology. 2016. PMID: 27511182 Free PMC article. Clinical Trial.

10

Positron emission tomography and magnetic resonance imaging for cerebral involvement in patients with systemic lupus erythematosus.

Sailer M, Burchert W, Ehrenheim C, Smid HG, Haas J, Wildhagen K, Wurster U, Deicher H. Sailer M, et al. J Neurol. 1997 Mar;244(3):186-93. doi: 10.1007/s004150050071. J Neurol. 1997. PMID: 9050960

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

257 results

Search Page

Filters